Regulatory & Legal

With promising data in cancer and eczema, all eyes are on Corvus Pharmaceuticals as it presents its lead drug at a major healthcare conference this week.

Top veterinary group endorses Visbiome Vet for chronic gut issues, setting a new evidence-based standard in a crowded, unregulated pet supplement market.

The digital media firm faces a Nasdaq compliance countdown after failing to file its annual report, revealing deeper issues of financial strain and SEC scrutiny.

As Mueller Water Products heads to a key industry symposium, a new CEO and record earnings set the stage for its vision for America's water future.

As cannabis use grows, new data reveals a deadly toll on Texas roads, with 120 deaths annually, sparking calls for action and a complex policy debate.

Airlines scramble to restore service to key Mexican tourist hubs after a violent cartel rampage forced hundreds of flight cancellations and stranded thousands.

Enbridge is offering two-decade-long gas transport deals, a major bet on the fuel's role in an era of energy transition and shifting climate policies.

A new $3M federal investment aims to help over 400 Prairie manufacturers navigate global trade volatility through advanced training and operational support.

A massive $12 billion data center investment from Amazon and STACK Infrastructure promises economic renewal for northwest Louisiana, but raises critical questions.

Small businesses warn of job losses and higher home costs as they face off against multinational giants in a trade dispute over imported quartz countertops.

A top legal award for David Wittmann reveals his crucial role in guiding Massachusetts' tech startups and his deep commitment to community service.

An analysis of 880,000 trade setups shows U.S. traders checked liquidation risk twice as often as global peers in 2025, signaling a maturing market.

A new wellness program by celebrity psychiatrist Dr. Daniel Amen is launching in churches, blending neuroscience with scripture to fight a national health crisis.

A former Regeneron exec who built a blockbuster drug joins a medtech startup, signaling a major push to disrupt the multi-billion dollar chemo-port market.

The punk band will hold a free acoustic show honoring Alex Pretti and Renée Good, raising funds for a community reeling from tragedy and federal action.

A leading bar association challenges the 'cost center' view, arguing New York's courts are a key driver of economic growth and tax revenue.

A new state-backed decal helps consumers spot legal cannabis sellers. Discover how the 'Verified Dispensary' program aims to ensure safety and combat illicit sales.

As Lachlan Murdoch prepares to address industry leaders, all eyes are on Fox's strategy for streaming, sports rights, and navigating a shifting media world.

Peter S. Thompson's leadership on the RetirePath program is gaining national praise, providing a blueprint for how states can tackle the retirement crisis.

Solana Company is building a massive infrastructure in Asia, but can this bold, high-risk play conquer the complex regulatory landscape and win the race?